STOCKWATCH
·
Medical/Nursing Services
Quarterly ResultMay 5, 2026, 04:08 PM

InnovAge Q3 Revenue Up 15.5% to $251.9M; Raises FY26 Guidance

AI Summary

InnovAge Holding Corp. announced its fiscal third-quarter 2026 financial results, reporting a 15.5% increase in total revenues to $251.9 million. Despite this, the company's net loss widened significantly to $29.9 million from $11.1 million in the prior year. However, Adjusted EBITDA saw substantial growth, increasing to $30.5 million. Based on its performance, InnovAge is raising its full fiscal year 2026 revenue and Adjusted EBITDA guidance.

Key Highlights

  • Total revenues increased 15.5% to $251.9 million in Q3 2026 from $218.1 million in Q3 2025.
  • Net loss was $29.9 million in Q3 2026, compared to a net loss of $11.1 million in Q3 2025.
  • Adjusted EBITDA rose 182.6% to $30.5 million in Q3 2026 from $10.8 million in Q3 2025.
  • Center-level Contribution Margin increased 49.8% to $61.0 million in Q3 2026 from $40.7 million in Q3 2025.
  • Fiscal 2026 revenue guidance raised to $950-$975 million.
  • Fiscal 2026 Adjusted EBITDA guidance raised to $85-$90 million.
  • Census was approximately 8,050 participants as of March 31, 2026, up from 7,530 in Q3 2025.
  • Ended Q3 2026 with $95.5 million in cash and cash equivalents.
INNV
Medical/Nursing Services
InnovAge Holding Corp.

Price Impact